DeepIntent Launches DeepIntent Outcomes™
Industry’s First Demand-Side Platform Integrated With Real-World Clinical Data to Increase Script Lift, Improving Business Outcomes for Healthcare Marketers Beta leading pharmaceutical brand experienced …
Industry’s First Demand-Side Platform Integrated With Real-World Clinical Data to Increase Script Lift, Improving Business Outcomes for Healthcare Marketers Beta leading pharmaceutical brand experienced …
Demonstrates gap between patients and providers about treatment options NEW YORK, March 25, 2021 – DeepIntent, the leading healthcare marketing technology company built purposefully …
Paquette honored amongst the brightest young stars in the evolving and expanding realm of healthcare marketing NEW YORK, February 22, 2021 – DeepIntent, the …
Company increased revenue by 300% for the fourth consecutive year while expanding its platform to offer customers the world’s most advanced data-driven healthcare advertising
HIPAA-certified end-to-end advertising solution is the industry’s first to effectively reach specific patient populations in a privacy-safe way
The Digiday Technology Awards recognize tech companies driving the digital media industry forward.
DeepIntent Additional Hires Support Growth of End-To-End Advertising Solution For Healthcare and Pharmaceutical Marketers
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Chris Paquette, Founder & CEO, DeepIntent as the 2020 Trailblazer Vanguard Award winner.
The healthcare-specialized CTV Marketplace is fully integrated with DeepIntent’s healthcare audiences, so advertisers can reach their custom Patient and HCP audiences immediately with CTV ads